Related by context. All words. (Click for frequent words.) 65 Nolvadex 65 tamoxifen Nolvadex ® 64 adriamycin 63 Cytoxan 63 anthracyclines 62 sorafenib Nexavar 62 Aromasin 62 pegylated liposomal doxorubicin 62 letrozole Femara 61 cyclophosphamide 61 exemestane 61 fluorouracil 61 Herceptin trastuzumab 61 cisplatin 61 Paraplatin ® 61 Platinol 61 5FU 61 imatinib Gleevec 61 flutamide 61 mycophenolate mofetil 60 eribulin 60 standard chemotherapy regimen 60 cyclophosphamide methotrexate 60 vinorelbine 60 Navelbine ® 60 erlotinib Tarceva ® 60 docetaxel chemotherapy 60 Taxotere 60 Gemzar ® 60 gemcitabine chemotherapy 60 exemestane Aromasin 59 Navelbine 59 bevacizumab 59 gefitinib Iressa 59 paclitaxel Taxol 59 bevacizumab Avastin 59 docetaxel Taxotere ® 59 5 fluorouracil 59 tamoxifen citrate 59 Camptosar 59 doxorubicin 59 Hycamtin 59 trastuzumab 59 relapsed ovarian cancer 59 lapatinib Tykerb 59 5 FU leucovorin 59 radiofrequency ablation RFA 59 alkylating agents 59 anthracycline taxane 59 temsirolimus 59 bevacizumab Avastin ® 59 XELOX 59 bicalutamide 59 tamoxifen 58 Fluorouracil 58 tinidazole 58 cetuximab 58 Eli Lilly Gemzar 58 interferon alfa 58 antihormonal 58 oxaliplatin 58 Faslodex 58 goserelin 58 estrogen receptor negative 58 Erlotinib 58 idarubicin 58 Fludara 58 chemotherapeutic regimens 58 Taxol ® 58 irinotecan chemotherapy 58 Zomig 58 Taxol paclitaxel 58 NOLVADEX 58 Irinotecan 58 Taxotere ® 58 ARIMIDEX 58 aromatase inhibitor 58 Tamoxifen 58 Torisel 58 Exemestane 58 cisplatin carboplatin 58 chemotherapy cisplatin 58 Doxil ® 58 Trastuzumab 58 epirubicin 57 Ixempra 57 Camptosar ® 57 Platinol ® cisplatin 57 Mylotarg 57 Yervoy 57 anti androgen 57 intravenous bisphosphonates 57 taxane chemotherapy 57 infusional 5-FU/LV 57 trastuzumab Herceptin 57 FOLFOX4 57 erlotinib 57 Oxaliplatin 57 Sanofi Aventis Taxotere 57 neoadjuvant chemotherapy 57 Pegintron 57 docetaxel Taxotere 57 erlotinib Tarceva 57 Abacavir 57 mitomycin 57 CHOP chemotherapy 57 dacarbazine 57 trabectedin 57 Cisplatin 57 cetuximab Erbitux ® 57 Tykerb 57 oxaliplatin Eloxatin 57 basiliximab 57 dexrazoxane 57 bleomycin 57 azathioprine 57 anastrozole 57 oral clodronate 57 VIDAZA 57 thalidomide Thalomid 57 fluvastatin 57 etoposide 57 gemcitabine Gemzar 57 temozolomide 57 Paraplatin ® carboplatin 57 Anastrozole 57 docetaxel 57 atorvastatin Lipitor 57 mitoxantrone 57 alpha interferons 57 tamoxifen Nolvadex 57 raloxifene Evista 57 5-FU/LV 56 topotecan 56 pravastatin Pravachol 56 clopidogrel Plavix 56 FUSILEV enhances 56 imatinib Gleevec ® 56 efavirenz Sustiva 56 TACE 56 tenofovir Viread 56 irbesartan 56 dasatinib Sprycel 56 Doxil 56 Targretin 56 chemoradiotherapy 56 trastuzumab Herceptin R 56 alkylating agent 56 pegfilgrastim 56 recurrent ovarian cancer 56 gefitinib 56 Halaven 56 Pemetrexed 56 cetuximab Erbitux 56 plus dexamethasone 56 Zolinza 56 cabazitaxel 56 standard chemotherapy regimens 56 chemotherapy regimen 56 Epivir 56 PegIntron 56 antiandrogen 56 Vincristine 56 FIRMAGON 56 metastatic colorectal 56 vincristine 56 mycophenolic acid 56 fludarabine 56 cediranib 56 bendamustine 56 uric acid lowering 56 Taxotere chemotherapy 56 gemcitabine carboplatin 56 carboplatin paclitaxel 56 panitumumab Vectibix 56 rituximab Rituxan 56 sorafenib tablets 56 Taxol 56 Cremophor 56 docetaxel Taxotere R 56 Fludarabine 56 Docetaxel 56 Pfizer Sutent 56 Casodex 56 cytotoxic therapy 56 postoperative chemotherapy 56 Tarceva TM 56 paclitaxel cisplatin 56 ELOXATIN 56 cisplatin gemcitabine 56 pertuzumab 56 Alkeran 56 AstraZeneca Arimidex 56 Rebetol 56 cidofovir 56 FOLFIRI 55 aromatase inhibitors 55 Gleevec imatinib 55 Gliadel Wafer 55 taxanes 55 taxane therapy 55 Mitomycin C 55 Votrient 55 paclitaxel Taxol ® 55 chlorambucil 55 chemotherapeutic agent 55 Folfox 55 amifostine 55 DOXIL 55 letrozole 55 Velcade bortezomib 55 calcineurin inhibitors 55 GnRH agonists 55 AVODART 55 Atacand 55 minoxidil 55 Genentech Herceptin 55 Telcyta 55 Gemcitabine 55 decitabine 55 Aldara 55 pegylated interferon alpha 55 captopril 55 cisplatin chemotherapy 55 TNF inhibitor 55 steroid prednisone 55 AZILECT 55 interferon alfa 2b 55 Jevtana 55 paclitaxel chemotherapy 55 pharmacologically active isomer 55 zoledronic acid 55 placebo dexamethasone 55 immunosuppressant 55 mTOR inhibitor 55 sorafenib 55 nonmelanoma skin cancers 55 tyrosine kinase inhibitors 55 metastatic malignant 55 ethambutol 55 Interferon beta 55 AVASTIN 55 gadobutrol 55 doxazosin 55 amphotericin B 55 azacitidine 55 Gemzar 55 docetaxel prednisone 55 antimetabolite 55 Platinol ® 55 Bevacizumab Avastin 55 chemotherapy docetaxel 55 ReoPro 55 Taxotere docetaxel 55 sunitinib Sutent 55 DOXIL ® 55 metastatic renal cell carcinoma 55 abacavir lamivudine 55 clodronate 55 squamous histology 55 daunorubicin 55 Sorafenib 55 chemotherapeutic drug 55 Adjuvant chemotherapy 55 anidulafungin 55 Bevacizumab 55 Epirubicin 55 sertraline Zoloft 55 plus gemcitabine 55 cytotoxic chemotherapy 54 Carboplatin 54 zoledronate 54 5 fluorouracil leucovorin 54 allogeneic stem cell 54 EGFR inhibitors 54 ixabepilone 54 fluoropyrimidine 54 Rituxan rituximab 54 Novartis Zometa 54 CellCept 54 Raloxifene 54 CANCIDAS 54 efalizumab 54 Peg IFN 54 xanthine oxidase inhibitor 54 Arimidex 54 interferon alfa 2a 54 voriconazole 54 HER2 positive metastatic breast 54 lapatinib 54 Paraplatin 54 atrasentan 54 advanced hepatocellular carcinoma 54 capecitabine Xeloda 54 warfarin Coumadin 54 Pertuzumab 54 dasatinib 54 Temsirolimus 54 bortezomib 54 K ras mutations 54 Vfend 54 prostate cancer HRPC 54 capecitabine 54 leucovorin 54 pemetrexed 54 Azacitidine 54 Gemzar gemcitabine 54 Bexxar 54 Roche Pegasys 54 Gleevec imatinib mesylate 54 infliximab Remicade 54 cyclophosphamide chemotherapy 54 Hycamtin ® 54 aromatase inhibitors AIs 54 TMP SMX 54 celecoxib 54 pazopanib 54 anthracycline 54 neoadjuvant therapy 54 pyrazinamide 54 efavirenz EFV 54 platelet inhibitor 54 Leucovorin 54 dasatinib Sprycel ® 54 FOLFIRI alone 54 eflornithine 54 N acetylcysteine 54 Gefitinib 54 chemotherapy gemcitabine 54 gastrointestinal stromal tumors GIST 54 pamidronate 54 metastatic GIST 54 bezafibrate 54 Zocor simvastatin 54 Epoetin alfa 54 gemcitabine 54 stavudine d4T 54 vandetanib 54 tretinoin 54 vinca alkaloids 54 Myfortic 54 trastuzumab Herceptin ® 54 pegylated interferons 54 3TC lamivudine Epivir 54 endocrine therapies 54 Eraxis 54 taxol 54 TAXOL R 54 paclitaxel 54 valsartan 54 APTIVUS r 54 Azathioprine 54 Mepact 54 anticlotting 54 Flu Cy 54 sorafenib Nexavar ® 54 Lilly Gemzar 54 olmesartan 54 idraparinux 54 nonsmall cell lung cancer 54 mTOR inhibitors 54 imatinib 54 prednisone prednisolone 54 Cyclophosphamide 54 liposomal doxorubicin 54 degarelix 54 recurrent metastatic 54 PARP inhibitor 54 irinotecan 54 EBRT 54 irinotecan doxorubicin oxaliplatin paclitaxel 54 Trabectedin 54 paclitaxel Taxol R 54 d4T 54 tamoxifen therapy 54 levetiracetam Keppra 54 tenofovir emtricitabine 54 Noxafil 54 chemotherapies 54 gp# vaccine 54 cetuximab Erbitux R 54 dexamethasone Decadron 54 alpha blocker 54 indinavir 54 anti TNFs 54 doxorubicin HCl liposome injection 54 Novantrone 54 Fulvestrant 54 Cetuximab 54 chemoradiation 54 estrogen receptor positive 54 locoregional recurrence 54 Mitoxantrone 54 protease inhibitor PI 54 iniparib 54 tiotropium bromide 53 neoadjuvant 53 HER2 positive cancers 53 ABVD 53 advanced unresectable 53 Aflibercept 53 hormone deprivation 53 carmustine 53 adalimumab Humira 53 Roche Herceptin 53 ranibizumab Lucentis 53 FOLFOX chemotherapy 53 anticoagulant warfarin 53 Genentech Rituxan 53 candesartan 53 stage IIIB IV 53 anastrozole Arimidex 53 Campath alemtuzumab 53 dutasteride 53 visilizumab 53 zoledronic acid Zometa 53 risedronate 53 Camptosar ® irinotecan 53 concurrent chemoradiation 53 AZT zidovudine Retrovir 53 antiandrogens 53 sunitinib 53 Everolimus 53 tibolone 53 Vidaza ® 53 Amplimexon 53 IXEMPRA 53 Lenalidomide 53 adjuvant chemotherapy 53 pegylated interferon alfa 53 pomalidomide 53 recurrent NSCLC 53 metastatic hormone refractory 53 sulfonylurea 53 ZOLINZA 53 ACE inhibitor 53 radiation chemoradiation 53 alefacept 53 Dabigatran 53 Fludara ® 53 GnRH agonist 53 ximelagatran 53 hormone therapy estrogen 53 chemotherapeutic agents 53 mycosis fungoides 53 immunosuppressive therapies 53 trans retinoic acid 53 androgen deprivation 53 anticlotting drugs 53 Starlix 53 antiestrogen therapy 53 Ontak 53 Peginterferon 53 trans retinoic acid ATRA 53 EGFR tyrosine kinase inhibitors 53 Capecitabine 53 tamsulosin 53 lenalidomide dexamethasone 53 immune suppressing 53 regorafenib 53 debulking surgery 53 heparins 53 resectable 53 nonsteroidal 53 peginterferon alpha 2a 53 celecoxib Celebrex 53 stage IIIb IV 53 mapatumumab 53 chemotherapy FOLFOX 53 Taxotere R 53 recurrent VTE 53 Valcyte 53 taxane 53 fenofibric acid 53 luteinizing hormone releasing 53 nifedipine 53 sulphonylureas 53 TKI therapy 53 fluconazole 53 immunosuppressant drug 53 Avastin bevacizumab 53 leuprolide 53 anti angiogenic agent 53 Valproate 53 danazol 53 GW# [003] 53 preoperative chemotherapy 53 sunitinib malate 53 thromboembolisms 53 androgen deprivation therapy 53 BRAF inhibitor 53 Neulasta ® 53 bortezomib Velcade 53 3TC 53 Arixtra 53 fulvestrant 53 temozolomide TMZ 53 cyclophosphamide doxorubicin vincristine 53 palifermin 53 fondaparinux 53 zidovudine lamivudine 53 clot dissolving drug 53 mitoxantrone chemotherapy 53 Lapatinib 53 antiplatelet agent 53 LHRH agonist 53 Campath 53 hormone receptor negative 53 HuMax CD4 53 Ellence 53 Dasatinib 53 non squamous NSCLC 53 FOLFOX 53 eplerenone 53 Xeloda capecitabine 53 etanercept Enbrel 53 Celecoxib 53 vincristine doxorubicin 53 TYKERB 53 vinca alkaloid 53 Previously Untreated 53 salpingo oophorectomy 53 Crestor rosuvastatin 53 relapsed SCLC 53 metastatic colon cancer 53 5 Fluorouracil 53 trimethoprim sulfamethoxazole 53 spironolactone 53 selegiline 52 evaluating tivozanib 52 anthracycline chemotherapy 52 FOLFOX6 52 Sinemet 52 Eloxatin 52 ddI 52 TRISENOX 52 angiotensin converting enzyme ACE 52 temozolomide Temodar 52 differentiated thyroid 52 Copegus ribavirin 52 BEACOPP 52 TELINTRA 52 nelfinavir 52 sorafenib Nexavar R 52 venlafaxine 52 interferon gamma 1b 52 angiotensin II receptor blocker 52 KRAS mutations 52 mRCC 52 zidovudine AZT 52 gemcitabine cisplatin 52 Alemtuzumab 52 anti angiogenic agents 52 Nexavar sorafenib 52 nucleoside analog 52 anticholinergics 52 Arranon 52 cilengitide 52 ONTAK 52 ACE Inhibitors 52 recurrent glioblastoma multiforme 52 EGFR TKI 52 statin cholesterol lowering 52 abiraterone 52 doxorubicin cyclophosphamide 52 YONDELIS 52 unresectable tumors 52 neoadjuvant treatment 52 pemetrexed Alimta 52 receiving VICTRELIS 52 Colchicine 52 lenalidomide Revlimid R 52 IMiDs 52 chlorthalidone 52 FASLODEX 52 Gleevec 52 Ixabepilone 52 coxibs 52 epoprostenol 52 endometrial hyperplasia 52 Zortress 52 lipid lowering drugs 52 chemoembolization 52 Erbitux cetuximab 52 TORISEL 52 carboplatin 52 adjuvant radiotherapy 52 patients undergoing chemotherapy 52 unresectable 52 vorinostat 52 antiplatelet drugs 52 tyrosine kinase inhibitor 52 ticlopidine 52 inactive placebo 52 paclitaxel carboplatin 52 immunosuppressive regimen 52 Amrubicin 52 olanzapine Zyprexa 52 pimecrolimus 52 Xeloda ® 52 Trizivir 52 HER2 positive tumors 52 clomiphene 52 Metformin 52 TTF Therapy 52 Bezielle 52 Diovan HCT 52 cholinesterase inhibitor 52 Pegasys ® 52 bevacizumab Avastin R 52 Tacrolimus 52 anticlotting drug 52 TEMODAL 52 allopurinol 52 anastrazole 52 advanced adenomas 52 metastatic RCC 52 proteasome inhibitors 52 FK# 52 hydroxyurea 52 citalopram Celexa 52 TNF inhibitors 52 mutated KRAS gene 52 Hormonal therapy 52 Femara 52 microtubule inhibitor 52 Fareston 52 hormonal therapies 52 BAY #-# 52 levofloxacin 52 LHRH agonists 52 PEG Intron 52 nonmetastatic 52 mitomycin C 52 insulin sensitizers 52 R sorafenib tablets 52 Topotecan 52 leflunomide 52 Surgical resection 52 Vectibix 52 molecularly targeted 52 miconazole 52 fallopian tube carcinoma 52 Panitumumab 52 epirubicin cisplatin 52 lymph node removal 52 ganciclovir 52 Elidel 52 metformin 52 intra arterial chemotherapy 52 hydroxychloroquine 52 imipenem 52 Copegus 52 Zometa 52 antiangiogenic therapy 52 LHRH 52 insulin glargine 52 DFMO 52 Femara letrozole 52 CsA 52 folinic acid 52 verapamil 52 MabCampath 52 beclomethasone dipropionate 52 pegylated interferon alfa 2b 52 glatiramer 52 DMARDS 52 LHRH receptor positive 52 IRESSA 52 tocilizumab 52 FluCAM 52 thiazide diuretic 52 nucleoside analogue 52 Vinorelbine 52 Combination therapy 52 surgical debulking 52 EGFR mutation 52 COREG 52 Avastin 52 chemotherapy 52 Tykerb lapatinib 52 COMBIVIR 52 sirolimus 51 corticosteroid dexamethasone 51 stage IIIB 51 Egrifta 51 cytarabine 51 pegylated interferon alfa 2a 51 ALA PDT 51 abciximab 51 SERMs 51 pyridostigmine 51 oblimersen 51 myelosuppressive 51 Kepivance 51 Radiofrequency ablation 51 lamivudine 51 nicardipine 51 chemotherapeutic regimen 51 Anthracycline 51 nilotinib Tasigna ® 51 strontium ranelate 51 Vaprisol 51 vinblastine 51 immunosuppressive agents 51 5 FU 51 Novartis Gleevec 51 Zemplar 51 seminoma 51 Incivek 51 bladder cancers 51 oxybutynin 51 Herceptin 51 androgen ablation 51 Avastin Erbitux 51 tigecycline 51 Rebif ® 51 Ethyol 51 beta blocker 51 saline placebo 51 deferoxamine 51 Proleukin 51 KRAS mutation 51 conventional DMARDs 51 Panzem R NCD 51 curative resection 51 mycophenolate mofetil MMF 51 fluorouracil leucovorin 51 aspirin heparin 51 Pegylated Interferon 51 mCRC patients 51 antiestrogen 51 hematologic toxicity 51 superficial bladder cancer 51 alpha interferon 51 pan HDAC inhibitor 51 tremelimumab 51 Vidaza azacitidine 51 neutropenic patients 51 Vandetanib 51 Telintra 51 Tarceva erlotinib 51 GVAX 51 nilotinib Tasigna 51 fibrinolytic 51 pioglitazone Actos 51 malignant pleural mesothelioma 51 CoFactor 51 SIR Spheres 51 Cetuximab Erbitux 51 paroxetine Paxil 51 Temodar ® 51 stavudine 51 axitinib 51 cyclosporin 51 anthracycline containing 51 conjugated estrogen 51 Aromatase inhibitors 51 NMIBC 51 oral allopurinol 51 bone marrow suppression 51 metastatic bladder 51 Afinitor 51 Elotuzumab 51 receptor tyrosine kinase inhibitor 51 adjuvant therapy 51 DAPT 51 antifungal medication 51 peginterferon alfa 2b 51 Radiation therapy 51 Bayer Nexavar 51 aflibercept 51 ZACTIMA 51 Roche Xeloda 51 pioglitazone 51 Zoledronic acid 51 Torisel temsirolimus 51 tricyclic antidepressants 51 NRTIs 51 lumiliximab 51 EGFRIs 51 basal cell skin 51 Temozolomide 51 L dopa 51 FOLFIRINOX 51 aprepitant 51 Metastatic breast cancer 51 thiazolidinediones 51 chemotherapy regimens 51 durable remissions 51 colorectal cancer liver metastases 51 6 mercaptopurine 51 Tekamlo 51 Cytarabine 51 REYATAZ 51 Amgen Vectibix 51 Neoadjuvant 51 Avastin Tarceva 51 Allovectin 7 ® 51 paclitaxel poliglumex 51 Glaxo Tykerb 51 statin 51 5-fluorouracil/leucovorin 51 rFVIIa 51 BARACLUDE ® 51 tenofovir DF 51 Neupogen ® 51 indomethacin 51 cladribine 51 proteasome inhibitor 51 omalizumab 51 recurrent GBM 51 Protelos 51 basal cell cancers 51 radiochemotherapy 51 SCCHN 51 Sprycel 51 enfuvirtide 51 carvedilol 51 Protopic 51 overexpress HER2 51 conventional chemotherapies 51 Interferon alpha 51 lovastatin 51 hormone receptor positive 51 FOLFOX regimen 51 ifosfamide 51 low dose dexamethasone 51 endoxifen 51 anthracycline therapy 51 Iressa gefitinib 51 chronic lymphocytic leukemia CLL 51 paricalcitol 51 Novartis AG Gleevec 51 posaconazole 51 synthetic progestin 51 esomeprazole 51 KRAS mutations occur 51 adjuvant radiation 51 Orally administered 51 Imuran 51 epirubicin cyclophosphamide 51 relapsed MM 51 tenofovir 51 venlafaxine Effexor 51 oral chemotherapeutic agent 51 piperacillin tazobactam 51 enzastaurin 51 comparator arm 51 pancreatic adenocarcinoma 51 ALIMTA cisplatin 51 nucleoside reverse transcriptase inhibitors 51 prostate cancer CRPC 51 HER2 positive breast cancer 51 intraperitoneal chemotherapy 51 peginterferon 51 entecavir 51 cilostazol 51 Imatinib 50 Losartan 50 metastatic kidney 50 EPZICOM 50 cisplatin vinorelbine 50 leukotriene receptor antagonist 50 refractory AML 50 epoetin alfa 50 OPAXIO 50 Methotrexate 50 VFEND 50 Sorafenib Nexavar 50 liver metastasis 50 abatacept 50 hormonal therapy 50 teriparatide 50 relapsed CLL 50 figitumumab 50 CIMZIA ™ 50 gamma secretase inhibitors 50 unfractionated heparin 50 telaprevir dosed 50 immunomodulator 50 tegafur 50 Dacogen 50 Ziagen 50 estramustine 50 pravastatin 50 Adentri 50 nucleoside analogues 50 azacytidine 50 biologic DMARD 50 Xeloda 50 sunitinib Sutent ® 50 alteplase 50 Clolar 50 unresectable stage 50 cisplatin resistant 50 HMG CoA reductase inhibitors 50 platinum refractory 50 dacarbazine chemotherapy 50 chemoradiation therapy 50 ZACTIMA TM ZD# 50 acid suppressing 50 dose cytarabine 50 HERCEPTIN 50 Interferon alfa 50 antihypertensive agents 50 MyVax R 50 filgrastim 50 Abiraterone 50 Xinlay 50 taxotere 50 angiogenesis inhibitor 50 tricyclic antidepressant 50 BRCA deficient 50 Cyclosporine 50 plus prednisone 50 cyclophosphamide Cytoxan 50 angiotensin receptor blockers 50 HER2 negative 50 pimozide 50 plus prednisone prednisolone 50 Atrasentan 50 VELCADE melphalan 50 rituximab Rituxan ® 50 steroid dexamethasone 50 hypomethylating agents 50 Gleevec Glivec 50 Relapsed Refractory Multiple Myeloma 50 alpha 2a 50 sevelamer 50 ceftazidime 50 oral antidiabetic 50 Rilutek 50 intravenous cyclophosphamide 50 Paclitaxel 50 liposomal formulation 50 nab paclitaxel 50 low dose ritonavir 50 VEGF inhibitors 50 Cell Lymphoma CTCL 50 levosimendan 50 cranial radiation 50 reteplase 50 mg m² 50 ONCASPAR 50 ibandronate 50 amoxicillin clavulanate 50 Myelodysplastic Syndrome MDS 50 Riluzole 50 doublet chemotherapy 50 sertraline 50 glatiramer acetate 50 ADP receptor antagonist 50 epoetin beta 50 thienopyridine 50 meropenem 50 olaparib 50 forskolin 50 Caelyx 50 Belldegrun 50 pancreatic lung 50 Avastin Herceptin 50 cytoreductive surgery 50 Arcalyst 50 pantoprazole 50 MMP inhibitors 50 Abiraterone acetate 50 TAXOTERE ® 50 Celsentri 50 Genasense 50 PEGylated Fab fragment 50 sirolimus eluting stent 50 QVA# 50 xenograft models 50 Etoposide 50 arsenic trioxide 50 nadolol 50 injected subcutaneously 50 cranial irradiation 50 Sutent sunitinib 50 Zometa zoledronic acid 50 Eloxatin ® 50 Traficet EN 50 ceftriaxone 50 GEMZAR 50 octreotide LAR 50 mitoxantrone plus 50 chimeric monoclonal antibody 50 febuxostat 50 LEXIVA r 50 DU #b 50 AROMASIN 50 Aliskiren 50 interferon therapy 50 Celebrex celecoxib 50 ribavirin RBV 50 pancreatic neuroendocrine tumors 50 stage IIIA 50 interferon